General Provisions for Schedules attached to The Law of Combating Narcotic drugs and Psychotropic Substances
2024-11-26
Drugs
Drugs
Contingency plans to reduce the risks of using formula (EXJADE ® (Deferasirox
| Publication Date |
|
| Applying Date |
|
Circular Clinical Trial on drugs
| Publication Date |
|
| Applying Date |
2012-12-05
|
SFDA requirements for labeling and Packaging for investigational medicinal products (IMP)
| Publication Date |
|
| Applying Date |
2012-12-05
|
Increased Risk of Death Associated With Use of Tigecycline) Tygacil®)
| Publication Date |
|
| Applying Date |
2013-12-09
|
Cough and cold medications should not be used for infants and children <6 years of age
| Publication Date |
|
| Applying Date |
2013-12-09
|
Safety warning : Peripheral neuropathy and telbivudine
| Publication Date |
|
| Applying Date |
2013-12-09
|
Safety Warning of Renal Dysfunction associated with the use of Aclasta®
| Publication Date |
|
| Applying Date |
2013-12-09
|
Safety Warning of accidental overdose reported in infants and children with intravenous paracetamol 10mg/mL solution for infusion (Perfalgan®)
| Publication Date |
|
| Applying Date |
2013-12-09
|
Announcing the release of the second version of the electronic reporting system for adverse drug reaction
| Publication Date |
|
| Applying Date |
2013-12-09
|